World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
59
Citations
16717
World Ranking
3219
National Ranking
286

Overview

Karl G. Nicholson is affiliated with the University of Leicester in the United Kingdom. Their research primarily explores fields within Medicine, focusing notably on Epidemiology, Pulmonary and Respiratory Medicine, Infectious Diseases, and Public Health, Environmental and Occupational Health.

Their work addresses specific topics such as:

  • Respiratory viral infections research
  • Infection Control and Ventilation
  • Viral gastroenteritis research and epidemiology
  • Ectopic Pregnancy Diagnosis and Management

Karl G. Nicholson has contributed articles to several scientific journals, prominently including:

  • Journal of Infection
  • Journal of Minimally Invasive Gynecology

Two recent papers showcase their research scope:

  • "Respiratory virus transmission using a novel viral challenge model: An observational cohort study," published in 2022 in the Journal of Infection
  • "Robotic-Assisted Laparoscopic Resection of a Cornual Ectopic Pregnancy: Video Presentation," published in 2021 in the Journal of Minimally Invasive Gynecology

The scientist has collaborated with multiple co-authors over their recent projects. Frequent collaborators include:

  • Marie-Jo Medina
  • Joshua Nazareth
  • Helen M. Dillon
  • Christopher J. Wighton
  • Srini Bandi

Best Publications

  • Respiratory viruses and exacerbations of asthma in adults.

    K G Nicholson;J Kent;D C Ireland

  • Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection.

    Bautista E;Chotpitayasunondh T;Gao Z

  • Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial

    K. G. Nicholson;F. Y. Aoki;A. D. M. E. Osterhaus;S. Trottier

  • Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections

    Frederick G. Hayden;Albert D.M.E. Osterhaus;John J. Treanor;Douglas M. Fleming

  • Influenza

    Unknown

  • Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine : a randomised trial of two potential vaccines against H5N1 influenza

    Karl G Nicholson;Anthony E Colegate;Audino Podda;Iain Stephenson

  • Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden

    Karl G Nicholson;Julie Kent;Victoria Hammersley;Esperanza Cancio

  • Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials.

    Nicola J Cooper;Alexander J Sutton;Keith R Abrams;Allan Wailoo

  • Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

    Tristan W. Clark;Manish Pareek;Katja Hoschler;Helen Dillon

  • Cross-Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses after Vaccination with Nonadjuvanted and MF59-Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming Strategy

    Iain Stephenson;Iain Stephenson;Roberto Bugarini;Karl G. Nicholson;Audino Podda

  • Procalcitonin and C-Reactive Protein in Hospitalized Adult Patients With Community-Acquired Pneumonia or Exacerbation of Asthma or COPD

    Mona Bafadhel;Tristan W. Clark;Carlene Reid;Marie-jo Medina

  • Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine

    Grazia Galli;Kathy Hancock;Katja Hoschler;Joshua DeVos

  • Systematic review and economic decision modelling for the prevention and treatment of influenza A and B

    David A. Turner;Allan J. Wailoo;Karl G. Nicholson;N. Cooper

  • Confronting the avian influenza threat: vaccine development for a potential pandemic

    Iain Stephenson;Iain Stephenson;Karl G Nicholson;John M Wood;Maria C Zambon

  • Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population

    Iain Stephenson;Karl G Nicholson;Anthony Colegate;Audino Podda

  • Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine

    I Stephenson;J.M Wood;K.G Nicholson;A Charlett

  • Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990.

    K. G. Nicholson

  • Neuraminidase Inhibitor Resistance after Oseltamivir Treatment of Acute Influenza A and B in Children

    Iain Stephenson;Jane Democratis;Angie Lackenby;Teresa McNally

  • Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin

    I. Stephenson;J.M. Wood;K.G. Nicholson;M.C. Zambon

  • Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial.

    Iain Stephenson;Karl G Nicholson;Reinhardt Glück;Robert Mischler

  • Effects of upper respiratory tract infections in patients with cystic fibrosis.

    J Collinson;K G Nicholson;E Cancio;J Ashman

  • Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study

    Karl G Nicholson;Julie Kent;Victoria Hammersley;Esperanza Cancio

  • Influenza immunization policies in Europe and the United States

    Karl G. Nicholson;René Snacken;Abraham M. Palache

Frequent Co-Authors

Maria Zambon
Maria Zambon Public Health England
Keith R. Abrams
Keith R. Abrams University of Leicester
Jonathan S. Nguyen-Van-Tam
Jonathan S. Nguyen-Van-Tam University of Nottingham
Robert C. Read
Robert C. Read University of Southampton
Michael R. Barer
Michael R. Barer University of Leicester
Peter J. M. Openshaw
Peter J. M. Openshaw Imperial College London
John Wood
John Wood National Institute for Biological Standards and Control
Jacqueline M. Katz
Jacqueline M. Katz Emory University
Christopher E. Brightling
Christopher E. Brightling University of Leicester
Timothy M. Uyeki
Timothy M. Uyeki Centers for Disease Control and Prevention

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA can open doors to diverse career paths beyond traditional laboratory roles. Many professionals find opportunities in healthcare and information management, blending scientific knowledge with patient care or data analysis. For those interested in integrating clinical practice with a holistic approach, pursuing a functional medicine nurse salary can reflect the rewarding compensation available in this growing field.

Moreover, health information is critical in microbiology-related sectors, leading to careers like Certified Professional Coder (CPC). Learning about certified professional coder (cpc) opportunities can guide students toward roles combining healthcare knowledge and coding expertise, essential for medical billing and documentation.

Another promising route is becoming a Health Information Manager. Understanding the health information manager salary and career outlook helps students weigh the benefits of managing healthcare data systems, ensuring compliance and efficient information flow in medical settings.

To support these career paths, many students turn to online health information management programs cahiim accredited, which offer flexible, reputable education options for advancing in health information management while balancing other commitments. These programs help integrate microbiology knowledge with healthcare information skills, enhancing career prospects.

Best Scientists Citing Karl G. Nicholson

Trending Scientists

Recently Published Articles